Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Q32 Bio Inc. (QTTB) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Q32 Bio Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1661998.
Total stock buying since 2018: $51,999,992.
Total stock sales since 2018: $109,880,366.
Total stock option exercises since 2018: $210,512.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 17,724 | $31,919 | 0 | $0 |
| 2024 | 0 | $0 | 9,596 | $19,811 | 77,797 | $99,506 |
| 2023 | 0 | $0 | 14,365 | $20,235 | 11,549 | $0 |
| 2022 | 0 | $0 | 12,264 | $46,355 | 32,670 | $0 |
| 2021 | 0 | $0 | 53,786 | $666,136 | 26,500 | $72,426 |
| 2020 | 0 | $0 | 3,211,781 | $44,321,934 | 18,000 | $11,376 |
| 2019 | 533,333 | $11,999,992 | 1,957,784 | $41,528,146 | 52,806 | $27,204 |
| 2018 | 2,500,000 | $40,000,000 | 1,142,314 | $23,245,830 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 17,724 | $31,919 | 0 | $0 |
| 2024-10 | 0 | $0 | 0 | $0 | 23,874 | $99,506 |
| 2024-03 | 0 | $0 | 608 | $14,716 | 31,073 | $0 |
| 2024-01 | 0 | $0 | 8,988 | $5,095 | 22,850 | $0 |
| 2023-09 | 0 | $0 | 1,448 | $1,665 | 4,620 | $0 |
| 2023-08 | 0 | $0 | 1,952 | $2,704 | 6,929 | $0 |
| 2023-03 | 0 | $0 | 10,965 | $15,866 | 0 | $0 |
| 2022-01 | 0 | $0 | 12,264 | $46,355 | 32,670 | $0 |
| 2021-09 | 0 | $0 | 54 | $415 | 0 | $0 |
| 2021-03 | 0 | $0 | 6,232 | $69,561 | 4,000 | $19,052 |
| 2021-02 | 0 | $0 | 18,000 | $248,389 | 18,000 | $31,007 |
| 2021-01 | 0 | $0 | 29,500 | $347,771 | 4,500 | $22,367 |
| 2020-12 | 0 | $0 | 2,000,000 | $25,290,000 | 0 | $0 |
| 2020-03 | 0 | $0 | 1,315 | $17,108 | 0 | $0 |
| 2020-02 | 0 | $0 | 24,500 | $395,897 | 12,000 | $7,584 |
| 2020-01 | 0 | $0 | 1,185,966 | $18,618,929 | 6,000 | $3,792 |
| 2019-12 | 0 | $0 | 542,530 | $11,720,913 | 6,000 | $3,840 |
| 2019-11 | 0 | $0 | 27,800 | $445,947 | 16,806 | $4,164 |
| 2019-10 | 0 | $0 | 27,800 | $495,059 | 6,000 | $3,840 |
| 2019-09 | 0 | $0 | 28,966 | $544,278 | 6,000 | $3,840 |
| 2019-08 | 0 | $0 | 27,800 | $482,823 | 6,000 | $3,840 |
| 2019-07 | 0 | $0 | 35,800 | $690,462 | 6,000 | $3,840 |
| 2019-06 | 0 | $0 | 37,088 | $740,564 | 6,000 | $3,840 |
| 2019-05 | 0 | $0 | 1,230,000 | $26,408,100 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-26 | Violette Shelia M. (Chief Scientific Officer) | Sale | 2,990 | 1.80 | 5,384 |
| 2025-08-26 | Kalowski Lee (CFO and President) | Sale | 4,240 | 1.80 | 7,636 |
| 2025-08-26 | Morrison Jodie Pope (CEO) | Sale | 10,494 | 1.80 | 18,899 |
| 2024-10-15 | Violette Shelia M. (Chief Scientific Officer) | Option Ex | 6,000 | 7.29 | 43,740 |
| 2024-10-11 | Violette Shelia M. (Chief Scientific Officer) | Option Ex | 4,574 | 3.12 | 14,270 |
| 2024-10-08 | Violette Shelia M. (Chief Scientific Officer) | Option Ex | 13,300 | 3.12 | 41,496 |
| 2024-03-25 | Michaud Charles Jr (See Remarks) | Sale | 75 | 24.20 | 1,815 |
| 2024-03-25 | Michaud Charles Jr (See Remarks) | Option Ex | 6,448 | .00 | 0 |
| 2024-03-25 | Alloway Paul (See Remarks) | Sale | 268 | 24.21 | 6,488 |
| 2024-03-25 | Alloway Paul (See Remarks) | Option Ex | 23,530 | .00 | 0 |
| 2024-03-25 | Tzianabos Arthur | Sale | 265 | 24.20 | 6,413 |
| 2024-03-25 | Tzianabos Arthur | Option Ex | 1,095 | .00 | 0 |
| 2024-01-03 | Michaud Charles Jr (See Remarks) | Sale | 1,708 | .57 | 975 |
| 2024-01-03 | Alloway Paul (See Remarks) | Sale | 7,280 | .57 | 4,120 |
| 2024-01-01 | Michaud Charles Jr (See Remarks) | Option Ex | 4,240 | .00 | 0 |
| 2024-01-01 | Alloway Paul (See Remarks) | Option Ex | 18,610 | .00 | 0 |
| 2023-09-06 | Seymour Albert (See Remarks) | Sale | 1,448 | 1.15 | 1,665 |
| 2023-09-06 | Seymour Albert (See Remarks) | Option Ex | 4,620 | .00 | 0 |
| 2023-08-03 | Jordan Julie (Chief Medical Officer) | Sale | 1,853 | 1.39 | 2,575 |
| 2023-08-03 | Jordan Julie (Chief Medical Officer) | Option Ex | 6,579 | .00 | 0 |
| 2023-08-02 | Jordan Julie (Chief Medical Officer) | Sale | 99 | 1.31 | 129 |
| 2023-08-02 | Jordan Julie (Chief Medical Officer) | Option Ex | 350 | .00 | 0 |
| 2023-03-02 | Alloway Paul (See Remarks) | Sale | 10,965 | 1.45 | 15,866 |
| 2022-01-05 | Cohn Gabriel (Chief Medical Officer) | Sale | 1,661 | 3.78 | 6,278 |
| 2022-01-05 | Kelly Timothy P (Chief Operating Officer) | Sale | 1,406 | 3.78 | 5,314 |
| 2022-01-05 | Seymour Albert (Chief Scientific Officer) | Sale | 1,661 | 3.78 | 6,278 |
| 2022-01-05 | Tzianabos Arthur (President & CEO) | Sale | 5,354 | 3.78 | 20,238 |
| 2022-01-05 | Smith W Bradford (CFO & Treasurer) | Sale | 2,182 | 3.78 | 8,247 |
| 2022-01-01 | Cohn Gabriel (Chief Medical Officer) | Option Ex | 4,290 | .00 | 0 |
| 2022-01-01 | Kelly Timothy P (Chief Operating Officer) | Option Ex | 3,630 | .00 | 0 |
| 2022-01-01 | Seymour Albert (Chief Scientific Officer) | Option Ex | 4,290 | .00 | 0 |
| 2022-01-01 | Tzianabos Arthur (President & CEO) | Option Ex | 13,860 | .00 | 0 |
| 2022-01-01 | Smith W Bradford (CFO & Treasurer) | Option Ex | 6,600 | .00 | 0 |
| 2021-09-03 | Kelly Timothy P (See Remarks.) | Sale | 54 | 7.70 | 415 |
| 2021-03-01 | Kelly Timothy P (See Remarks.) | Sale | 6,232 | 11.16 | 69,561 |
| 2021-03-01 | Kelly Timothy P (See Remarks.) | Option Ex | 4,000 | 4.76 | 19,052 |
| 2021-02-08 | Smith W Bradford (CFO & Treasurer) | Sale | 13,500 | 14.25 | 192,429 |
| 2021-02-08 | Smith W Bradford (CFO & Treasurer) | Option Ex | 13,500 | .64 | 8,640 |
| 2021-02-02 | Kelly Timothy P (See Remarks) | Sale | 500 | 13.00 | 6,500 |
| 2021-02-02 | Kelly Timothy P (See Remarks) | Option Ex | 500 | 6.63 | 3,315 |
| 2021-02-01 | Kelly Timothy P (See Remarks) | Sale | 4,000 | 12.37 | 49,460 |
| 2021-02-01 | Kelly Timothy P (See Remarks) | Option Ex | 4,000 | 4.76 | 19,052 |
| 2021-01-12 | Kelly Timothy P (See Remarks) | Sale | 500 | 13.00 | 6,500 |
| 2021-01-12 | Kelly Timothy P (See Remarks) | Option Ex | 500 | 6.63 | 3,315 |
| 2021-01-07 | Seymour Albert (Chief Scientific Officer) | Sale | 5,103 | 12.05 | 61,470 |
| 2021-01-06 | Seymour Albert (Chief Scientific Officer) | Sale | 9,897 | 12.06 | 119,397 |
| 2021-01-05 | Seymour Albert (Chief Scientific Officer) | Sale | 10,000 | 11.44 | 114,420 |
| 2021-01-04 | Kelly Timothy P (See Remarks) | Sale | 4,000 | 11.50 | 45,984 |
| 2021-01-04 | Kelly Timothy P (See Remarks) | Option Ex | 4,000 | 4.76 | 19,052 |
| 2020-12-22 | Parmar Kush (Director) | Sale | 500,000 | 12.82 | 6,410,000 |
| 2020-12-22 | Schwab Andrew J. (10% Owner) | Sale | 500,000 | 12.82 | 6,410,000 |
| 2020-12-14 | Parmar Kush (Director) | Sale | 500,000 | 12.47 | 6,235,000 |
| 2020-12-14 | Schwab Andrew J. (10% Owner) | Sale | 500,000 | 12.47 | 6,235,000 |
| 2020-03-17 | Kelly Timothy P (See Remarks) | Sale | 1,315 | 13.01 | 17,108 |
| 2020-02-03 | Tzianabos Arthur (President & CEO) | Sale | 12,500 | 16.16 | 202,025 |
| 2020-02-03 | Smith W Bradford (CFO, Treasurer & Secretary) | Sale | 12,000 | 16.16 | 193,872 |
| 2020-02-03 | Smith W Bradford (CFO, Treasurer & Secretary) | Option Ex | 12,000 | .63 | 7,584 |
| 2020-01-30 | Deerfield Mgmt Hif, L.p. | Sale | 509,970 | 15.45 | 7,879,036 |
| 2020-01-29 | Deerfield Mgmt Hif, L.p. | Sale | 8,857 | 15.45 | 136,805 |
| 2020-01-28 | Deerfield Mgmt Hif, L.p. | Sale | 65,891 | 15.51 | 1,021,969 |
| 2020-01-27 | Deerfield Mgmt Hif, L.p. | Sale | 193,359 | 15.77 | 3,049,658 |
| 2020-01-24 | Deerfield Mgmt Hif, L.p. | Sale | 380,256 | 15.69 | 5,965,075 |
| 2020-01-02 | Seymour Albert (Chief Scientific Officer) | Sale | 9,133 | 20.50 | 187,217 |
| 2020-01-02 | Tzianabos Arthur (President & CEO) | Sale | 12,500 | 20.50 | 256,187 |
| 2020-01-02 | Smith W Bradford (CFO, Treasurer & Secretary) | Sale | 6,000 | 20.50 | 122,982 |
| 2020-01-02 | Smith W Bradford (CFO, Treasurer & Secretary) | Option Ex | 6,000 | .63 | 3,792 |
| 2019-12-24 | Deerfield Mgmt Hif, L.p. | Sale | 350,000 | 21.95 | 7,682,500 |
| 2019-12-23 | Deerfield Mgmt Hif, L.p. | Sale | 130,979 | 21.83 | 2,859,140 |
| 2019-12-20 | Deerfield Mgmt Hif, L.p. | Sale | 21,129 | 21.50 | 454,273 |
| 2019-12-19 | Deerfield Mgmt Hif, L.p. | Sale | 12,622 | 21.68 | 273,594 |
| 2019-12-02 | Seymour Albert (Chief Scientific Officer) | Sale | 9,300 | 16.23 | 150,966 |
| 2019-12-02 | Tzianabos Arthur (President & CEO) | Sale | 12,500 | 16.25 | 203,175 |
| 2019-12-02 | Smith W Bradford (CFO, Treasurer & Secretary) | Sale | 6,000 | 16.21 | 97,265 |
| 2019-12-02 | Smith W Bradford (CFO, Treasurer & Secretary) | Option Ex | 6,000 | .64 | 3,840 |
| 2019-11-29 | Seymour Albert (Chief Scientific Officer) | Sale | 9,300 | 16.06 | 149,385 |
| 2019-11-29 | Tzianabos Arthur (President & CEO) | Sale | 12,500 | 16.05 | 200,562 |
| 2019-11-29 | Smith W Bradford (CFO, Treasurer & Secretary) | Sale | 6,000 | 16.00 | 96,000 |
| 2019-11-29 | Smith W Bradford (CFO, Treasurer & Secretary) | Option Ex | 6,000 | .64 | 3,840 |
| 2019-11-18 | Gregory Richard J. (Director) | Option Ex | 10,806 | .03 | 324 |
| 2019-10-01 | Seymour Albert (Chief Scientific Officer) | Sale | 9,300 | 17.81 | 165,605 |
| 2019-10-01 | Tzianabos Arthur (President & CEO) | Sale | 12,500 | 17.81 | 222,624 |
| 2019-10-01 | Smith W Bradford (CFO, Treasurer & Secretary) | Sale | 6,000 | 17.80 | 106,830 |
| 2019-10-01 | Smith W Bradford (CFO, Treasurer & Secretary) | Option Ex | 6,000 | .64 | 3,840 |
| 2019-09-05 | Kelly Timothy P (See Remarks) | Sale | 1,166 | 19.94 | 23,251 |
| 2019-09-03 | Seymour Albert (Chief Scientific Officer) | Sale | 9,300 | 18.74 | 174,282 |
| 2019-09-03 | Tzianabos Arthur (President & CEO) | Sale | 12,500 | 18.75 | 234,324 |
| 2019-09-03 | Smith W Bradford (CFO, Treasurer & Secretary) | Sale | 6,000 | 18.74 | 112,421 |
| 2019-09-03 | Smith W Bradford (CFO, Treasurer & Secretary) | Option Ex | 6,000 | .64 | 3,840 |
| 2019-08-01 | Seymour Albert (Chief Scientific Officer) | Sale | 9,300 | 17.37 | 161,522 |
| 2019-08-01 | Tzianabos Arthur (President & CEO) | Sale | 12,500 | 17.37 | 217,112 |
| 2019-08-01 | Smith W Bradford (CFO, Treasurer & Secretary) | Sale | 6,000 | 17.36 | 104,189 |
| 2019-08-01 | Smith W Bradford (CFO, Treasurer & Secretary) | Option Ex | 6,000 | .64 | 3,840 |
| 2019-07-09 | Rasty Siyamak (Chief Operating Officer) | Sale | 8,000 | 20.00 | 160,000 |
| 2019-07-01 | Seymour Albert (Chief Scientific Officer) | Sale | 9,300 | 19.27 | 179,192 |
| 2019-07-01 | Tzianabos Arthur (President & CEO) | Sale | 12,500 | 18.98 | 237,300 |
| 2019-07-01 | Smith W Bradford (CFO, Treasurer & Secretary) | Sale | 6,000 | 19.00 | 113,970 |
| 2019-07-01 | Smith W Bradford (CFO, Treasurer & Secretary) | Option Ex | 6,000 | .64 | 3,840 |
| 2019-06-03 | Kelly Timothy P (See Remarks) | Sale | 1,288 | 20.00 | 25,765 |
| 2019-06-03 | Rasty Siyamak (Chief Operating Officer) | Sale | 8,000 | 20.22 | 161,776 |
| 2019-06-03 | Seymour Albert (Chief Scientific Officer) | Sale | 9,300 | 19.90 | 185,097 |
| 2019-06-03 | Tzianabos Arthur (President & CEO) | Sale | 12,500 | 19.86 | 248,262 |
| 2019-06-03 | Smith W Bradford (CFO, Treasurer & Secretary) | Sale | 6,000 | 19.94 | 119,664 |
| 2019-06-03 | Smith W Bradford (CFO, Treasurer & Secretary) | Option Ex | 6,000 | .64 | 3,840 |
| 2019-05-16 | Parmar Kush (Director) | Sale | 615,000 | 21.47 | 13,204,050 |
| 2019-05-16 | 5am Co-investors Iv, L.p. (10% Owner) | Sale | 615,000 | 21.47 | 13,204,050 |
| 2019-04-12 | Deerfield Mgmt Hif, L.p. | Buy | 533,333 | 22.50 | 11,999,992 |
| 2018-12-10 | Parmar Kush (Director) | Sale | 15,575 | 26.00 | 405,027 |
| 2018-12-10 | 5am Co-investors Iv, L.p. (10% Owner) | Sale | 15,575 | 26.00 | 405,027 |
| 2018-11-23 | Parmar Kush (Director) | Sale | 29,682 | 20.04 | 594,708 |
| 2018-11-23 | 5am Co-investors Iv, L.p. (10% Owner) | Sale | 29,682 | 20.04 | 594,708 |
| 2018-11-16 | Parmar Kush (Director) | Sale | 525,900 | 20.20 | 10,623,180 |
| 2018-11-16 | 5am Co-investors Iv, L.p. (10% Owner) | Sale | 525,900 | 20.20 | 10,623,180 |
| 2018-04-02 | Vv Manager Llc (10% Owner) | Buy | 375,000 | 16.00 | 6,000,000 |
| 2018-04-02 | Rock Springs Capital Llc (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2018-04-02 | Deerfield Mgmt Hif, L.p. | Buy | 1,250,000 | 16.00 | 20,000,000 |
| 2018-04-02 | V-sciences Investments Pte Ltd (10% Owner) | Buy | 625,000 | 16.00 | 10,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of QTTB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Q32 Bio Inc. (symbol QTTB, CIK number 1661998) see the Securities and Exchange Commission (SEC) website.